Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience: Nicolas Barthelemy

Twist Bioscience has appointed Nicolas Barthelemy to its board of directors. Barthelemy has more than 25 years of experience in the life science industry, the company said. Most recently, he served as president and CEO of privately held molecular diagnostics company Biotheranostics. He has also served as president of global commercial operations at Life Technologies (now Thermo Fisher Scientific), and has served in various operational and commercial roles, including as vice president of manufacturing for Biogen. He began his career with Merck as a project engineer in the vaccine division. Barthelemy currently also serves on the board of Repligen, Fluidigm, Biocare Medical, and 908 Devices.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.